Journal profile

BMC ophthalmology

Publisher: BioMed Central
ISSN1471-2415 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.73
Citation rate 2.86 2,945 total citations
h5-index 40 h5 depth signal
Cited share 77.2% 828 of 1,072
Total citations 2,945 Citation footprint
Metric signal 2.76 External metric anchor
Self-citation 4.4% 129 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 2,417
United States 415
South Korea 402
Japan 337
Turkey 296

Citing Fields of Research

Ophthalmology 4,777
Cosmetic Surgery 194
Auto-Inflammatory Disorders 90
Dermatology 85
Endocrinology & Metabolism 84

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 5,947 Articles tracked across the journal lifetime
Indexed publication set 1,072 828 cited publications
Last 12 months 990 82.5 publications/month
Open access share 100.0% 990 OA publications in the last year
Leading citing country China 2,417 citing publications
Leading citing field Ophthalmology 4,777 citing publications
Latest tracked publication 17 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1, 2001-
PubMed
v1, 2001-
PMC
Active Coverage
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Ophthalmology

Broad Categories

Ophthalmology

MeSH Descriptors

Eye Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

07
Adrian Konstantin Luyken, Claudia Brockmann, Valentin Junge et al.
Background: Proliferative vitreoretinopathy (PVR) remains the major cause of surgical failure in rhegmatogenous retinal detachment (RRD). This study evaluates the anatomical and functional outcomes, as well as the safety, of a standardiz...
09
Thippamas Pobsuk, Korawit Wangsirikul, Witoon Jantararotai et al.
Background: The optimal corticosteroid dose for treating ocular myasthenia gravis remains uncertain. Higher doses may increase the risk of adverse effects without providing additional clinical benefit. This study aimed to compare the eff...

Bibliographical & Catalog Notes

Title from BioMed Central archive volume screen (viewed on Feb. 20, 2002).

Articles are added consecutively to the current annual v.

Text (electronic journal) in HTML and PDF formats.

System requirements: Internet connectivity, World Wide Web browser, and Adobe Acrobat reader.

Mode of access: Internet.